Xtant Medical Holdings Inc. has announced the commercial launch of its next-generation synthetic bone graft, nanOss Strata™, expanding its orthobiologics portfolio. The new product is designed to more closely mimic human bone structure, increase graft surface area, and enhance osteoconductivity. nanOss Strata is now accessible through Xtant Medical's nationwide distribution network, further supporting the company's commitment to innovation in regenerative medicine and improved surgical outcomes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtant Medical Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA43731) on December 11, 2025, and is solely responsible for the information contained therein.
Comments